ACBM · Acro Biomedical Co., Ltd.
$0.03
At close · Jun 16
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of the financial statements being issued. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025, financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.56M
Shares
60.04M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$101.15K
-139.1%
FY2025
Gross Margin
21.34%
-0.3pp
FY2022
Operating Margin
-2409.98%
-1767.5pp
FY2022
Diluted EPS
$0.00
FY2025
Operating Cash Flow
-$196.3K
-435%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $0 | $0 | $658.5K | $1.2M | $687.96K | $193.54K | $8.01M | $510K | — | |
| — | — | — | $0 | $518K | $938K | $528.56K | $181.44K | $7.18M | $459K | — | |
| — | — | — | $0 | $140.5K | $259.5K | $159.4K | $12.1K | $833.4K | $51K | — | |
| — | — | — | — | 21.34% | 21.67% | 23.17% | 6.25% | 10.4% | 10% | — | |
| — | — | $0 | $4.79M | $10.08M | $5.29M | — | — | — | — | — | |
| $209.3K | $154.02K | $37.96K | $3.52M | $5.93M | $2.67M | $289.87K | $434.85K | $317.85K | $866 | $1055 | |
| $209.3K | $154.02K | $37.96K | $8.8M | $16.01M | $7.95M | $289.87K | $434.85K | $317.85K | $53.25K | $43.43K | |
| -$209.3K | -$154.02K | -$37.96K | -$8.8M | -$15.87M | -$7.69M | -$130.46K | -$422.75K | $515.55K | — | $43.43K | |
| — | — | — | — | -2409.98% | -642.47% | -18.96% | -218.44% | 6.43% | — | — | |
| — | — | — | $3206 | $1706 | $893 | $1067 | — | — | — | — | |
| — | $52.88K | -$4339 | — | — | — | -$5082 | -$1983 | -$3663 | — | — | |
| — | -$101.15K | -$42.3K | -$8.81M | -$15.87M | — | -$135.55K | -$424.73K | $511.89K | -$2248 | — | |
| — | $0 | $0 | $0 | $0 | $0 | -$18.09K | -$53.13K | $92.23K | $0 | — | |
| -$140.41K | -$101.15K | -$42.3K | -$8.81M | -$15.87M | -$7.7M | -$117.45K | -$371.6K | $419.66K | -$2248 | -$43.43K | |
| — | — | — | — | -2410.24% | -642.82% | -17.07% | -192.01% | 5.24% | -0.44% | — | |
| USD/shares | — | — | — | — | — | -$0.14 | $0.00 | — | — | — | — |
| USD/shares | $0.00 | $0.00 | $0.00 | -$0.15 | -$0.26 | — | — | — | — | — | — |
| shares | — | — | — | — | — | — | 47.76M | 47.76M | 47.66M | 47.17M | 15.72M |
| shares | — | 60.04M | 60.04M | 60.04M | 60.04M | 53.84M | 47.76M | 47.76M | 47.66M | 47.17M | 15.72M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—